to evaluate breadth and duration of protection conferred by OVX836 against seasonal and highly pathogenic influenza strains, informing its potential as a vaccine for long-term prevention of seasonal and pandemic influenza
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-051738
Grant search
Key facts
Disease
Unspecifiedstart year
2023Known Financial Commitments (USD)
$1,124,202Funder
Gates FoundationPrincipal Investigator
N/A
Research Location
FranceLead Research Institution
OsivaxResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Characterisation of vaccine-induced immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
N/A